1. Mou, Jie, Wang, Bei, Liu, Yuling, Zhang, Qi, Yuan, Chengfu. . FER1L4: A Long Non-coding RNA with Multiple Roles in the Occurrence and Development of Tumors. In Current pharmaceutical design, 28, 1334-1341. doi:10.2174/1381612828666220324141016. https://pubmed.ncbi.nlm.nih.gov/35331091/
2. Li, Yanping, Wang, Hui, Zhan, Liping, Wei, Huan, Dong, Xiaolin. 2022. LncRNA FER1L4 promotes differentiation and inhibits proliferation of NSCs via miR-874-3p/Ascl2. In American journal of translational research, 14, 2256-2266. doi:. https://pubmed.ncbi.nlm.nih.gov/35559379/
3. You, Zilong, Ge, Anqi, Pang, Da, Zhao, Yashuang, Xu, Shouping. 2019. Long noncoding RNA FER1L4 acts as an oncogenic driver in human pan-cancer. In Journal of cellular physiology, 235, 1795-1807. doi:10.1002/jcp.29098. https://pubmed.ncbi.nlm.nih.gov/31332783/
4. He, Jinhai, Wang, Li, Ding, Yajun, Liu, Hongbing, Zou, Guoyou. 2021. lncRNA FER1L4 is dysregulated in osteoarthritis and regulates IL-6 expression in human chondrocyte cells. In Scientific reports, 11, 13032. doi:10.1038/s41598-021-92474-8. https://pubmed.ncbi.nlm.nih.gov/34158566/
5. Yu, Huiming, Ding, Chao, Dai, Siming, Wang, Shuya, Zhang, Zhiyi. 2019. Long noncoding RNA FER1L4 regulates rheumatoid arthritis via targeting NLRC5. In Clinical and experimental rheumatology, 38, 713-723. doi:. https://pubmed.ncbi.nlm.nih.gov/31694750/
6. Xia, Liang, Nie, Dekang, Wang, Guangtao, Sun, Caixing, Chen, Gao. 2019. FER1L4/miR-372/E2F1 works as a ceRNA system to regulate the proliferation and cell cycle of glioma cells. In Journal of cellular and molecular medicine, 23, 3224-3233. doi:10.1111/jcmm.14198. https://pubmed.ncbi.nlm.nih.gov/30887657/
7. Kong, Y, Ren, Z. . Overexpression of LncRNA FER1L4 in endometrial carcinoma is associated with favorable survival outcome. In European review for medical and pharmacological sciences, 22, 8113-8118. doi:10.26355/eurrev_201812_16502. https://pubmed.ncbi.nlm.nih.gov/30556848/
8. Wang, Xu, Chen, Yunfei, Dong, Ke, Zhu, Xiaoshi, Wang, Shan. 2021. Effects of FER1L4-miR-106a-5p/miR-372-5p-E2F1 regulatory axis on drug resistance in liver cancer chemotherapy. In Molecular therapy. Nucleic acids, 24, 449-461. doi:10.1016/j.omtn.2021.02.006. https://pubmed.ncbi.nlm.nih.gov/33868788/
智鼠故事 
